SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-18-029559
Filing Date
2018-11-14
Accepted
2018-11-14 16:07:17
Documents
49
Period of Report
2018-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q life-10q_20180930.htm 10-Q 1499750
2 EX-10.1 life-ex101_11.htm EX-10.1 83990
3 EX-31.1 life-ex311_8.htm EX-31.1 9633
4 EX-31.2 life-ex312_6.htm EX-31.2 9683
5 EX-32.1 life-ex321_9.htm EX-32.1 5987
6 EX-32.2 life-ex322_7.htm EX-32.2 5947
7 GRAPHIC goclowb2ukgu000001.jpg GRAPHIC 26833
8 GRAPHIC goclowb2ukgu000002.jpg GRAPHIC 36510
  Complete submission text file 0001564590-18-029559.txt   5835439

Data Files

Seq Description Document Type Size
9 XBRL INSTANCE DOCUMENT life-20180930.xml EX-101.INS 1331428
10 XBRL TAXONOMY EXTENSION SCHEMA life-20180930.xsd EX-101.SCH 38814
11 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE life-20180930_cal.xml EX-101.CAL 39059
12 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE life-20180930_def.xml EX-101.DEF 158960
13 XBRL TAXONOMY EXTENSION LABEL LINKBASE life-20180930_lab.xml EX-101.LAB 316607
14 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE life-20180930_pre.xml EX-101.PRE 243166
Mailing Address 3545 JOHN HOPKINS COURT, STE #250 SAN DIEGO CA 92121
Business Address 3545 JOHN HOPKINS COURT, STE #250 SAN DIEGO CA 92121 858-731-8389
aTYR PHARMA INC (Filer) CIK: 0001339970 (see all company filings)

IRS No.: 203435077 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37378 | Film No.: 181183693
SIC: 2836 Biological Products, (No Diagnostic Substances)